Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A

Silvana Mourón, Miguel Quintela-Fandiño, Aňa Lluch et al.|Nature Communications|2022

Cited by 14